The Role of NLR-related Protein 3 Inflammasome in Host Defense and Inflammatory Diseases

Among a number of innate receptors, the nucleotide-binding domain leucine-rich repeat containing (NLR) nucleotide oligomerization domain (NOD)-like receptor families are involved in the recognition of cytosolic pathogen- or danger-associated molecules. Activation of these specific sets of receptors...

Full description

Saved in:
Bibliographic Details
Published inInternational neurourology journal Vol. 16; no. 1; pp. 2 - 12
Main Authors Yang, Chul-Su, Shin, Dong-Min, Jo, Eun-Kyeong
Format Journal Article
LanguageEnglish
Published Korea (South) Korean Continence Society 01.03.2012
대한배뇨장애요실금학회
Subjects
Online AccessGet full text
ISSN2093-4777
2093-6931
2093-6931
DOI10.5213/inj.2012.16.1.2

Cover

Loading…
More Information
Summary:Among a number of innate receptors, the nucleotide-binding domain leucine-rich repeat containing (NLR) nucleotide oligomerization domain (NOD)-like receptor families are involved in the recognition of cytosolic pathogen- or danger-associated molecules. Activation of these specific sets of receptors leads to the assembly of a multiprotein complex, the inflammasome, leading to the activation of caspase-1 and maturation of the cytokines interleukin (IL)-1β, IL-18, and IL-33. Among NLRs, NLR-related protein 3 (NLRP3) is one of the best-characterized receptors that activates the inflammasome. There is no doubt that NLRP3 inflammasome activation is important for host defense and effective pathogen clearance against fungal, bacterial, and viral infection. In addition, mounting evidence indicates that the NLRP3 inflammasome plays a role in a variety of inflammatory diseases, including gout, atherosclerosis, and type II diabetes, as well as under conditions of cellular stress or injury. Here, we review recent advances in our understanding of the role of the NLRP3 inflammasome in host defense and various inflammatory diseases.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
G704-001728.2012.16.1.004
ISSN:2093-4777
2093-6931
2093-6931
DOI:10.5213/inj.2012.16.1.2